Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
01 1PCAS Ecully FR
02 1MENADIONA, S.L. Palafolls ES
01 2Clomifene citrate
01 1France
02 1Spain
01 1Suspended by EDQM GMP non-compliance
02 1Valid
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Certificate Number : R1-CEP 2003-251 - Rev 06
Status : Valid
Issue Date : 2022-02-09
Type : Chemical
Substance Number : 997
Certificate Number : R1-CEP 2003-193 - Rev 04
Status : Suspended by EDQM GMP non-compliance
Issue Date : 2020-08-07
Type : Chemical
Substance Number : 997
A CLOMIPHENE-CITRATE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CLOMIPHENE-CITRATE, including repackagers and relabelers. The FDA regulates CLOMIPHENE-CITRATE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CLOMIPHENE-CITRATE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CLOMIPHENE-CITRATE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CLOMIPHENE-CITRATE supplier is an individual or a company that provides CLOMIPHENE-CITRATE active pharmaceutical ingredient (API) or CLOMIPHENE-CITRATE finished formulations upon request. The CLOMIPHENE-CITRATE suppliers may include CLOMIPHENE-CITRATE API manufacturers, exporters, distributors and traders.
click here to find a list of CLOMIPHENE-CITRATE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CLOMIPHENE-CITRATE CEP of the European Pharmacopoeia monograph is often referred to as a CLOMIPHENE-CITRATE Certificate of Suitability (COS). The purpose of a CLOMIPHENE-CITRATE CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CLOMIPHENE-CITRATE EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CLOMIPHENE-CITRATE to their clients by showing that a CLOMIPHENE-CITRATE CEP has been issued for it. The manufacturer submits a CLOMIPHENE-CITRATE CEP (COS) as part of the market authorization procedure, and it takes on the role of a CLOMIPHENE-CITRATE CEP holder for the record. Additionally, the data presented in the CLOMIPHENE-CITRATE CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CLOMIPHENE-CITRATE DMF.
A CLOMIPHENE-CITRATE CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CLOMIPHENE-CITRATE CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CLOMIPHENE-CITRATE suppliers with CEP (COS) on PharmaCompass.
LOOKING FOR A SUPPLIER?
